Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 5:32 pm Sale | 2025-06-30 | 13G | Roivant Sciences Ltd. ROIV | VIKING GLOBAL INVESTORS LP | 34,237,779 5.020% | -11,775,973 (-25.59%) | Filing History |
| 2025-08-14 4:39 pm Sale | 2025-06-30 | 13G | Roivant Sciences Ltd. ROIV | QVT Financial LP | 29,381,635 4.300% | -36,412,144 (-55.34%) | Filing History |
| 2025-08-07 3:04 pm Purchase | 2025-06-30 | 13G | Roivant Sciences Ltd. ROIV | MORGAN STANLEY MS | 37,646,676 5.500% | 37,646,676 (New Position) | Filing History |
| 2025-08-06 12:11 pm Purchase | 2025-06-30 | 13G | Roivant Sciences Ltd. ROIV | FMR LLC | 55,509,281 8.200% | 6,364,225 (+12.95%) | Filing History |
| 2025-05-15 6:53 pm Purchase | 2025-03-31 | 13G | Roivant Sciences Ltd. ROIV | Ramaswamy Vivek | 82,956,522 11.630% | 1 (+0.00%) | Filing History |
| 2025-05-15 5:29 pm Purchase | 2024-12-31 | 13G | Roivant Sciences Ltd. ROIV | Ramaswamy Vivek | 82,956,521 11.200% | 1,502,000 (+1.84%) | Filing History |
| 2025-05-15 4:35 pm Sale | 2025-03-31 | 13G | Roivant Sciences Ltd. ROIV | VIKING GLOBAL INVESTORS LP | 46,013,752 6.400% | -8,085,314 (-14.95%) | Filing History |
| 2025-04-21 07:54 am Unchanged | 2025-04-21 | 13D | Immunovant, Inc. IMVT | Roivant Sciences Ltd. ROIV | 96,660,341 56.900% | 0 (Unchanged) | Filing History |
| 2025-02-25 07:19 am Unchanged | 2025-02-21 | 13D | Arbutus Biopharma Corporation ABUS | Roivant Sciences Ltd. ROIV | 38,847,462 20.500% | 0 (Unchanged) | Filing History |
| 2025-02-18 5:21 pm Unchanged | 2025-02-18 | 13D | Arbutus Biopharma Corporation ABUS | Roivant Sciences Ltd. ROIV | 38,847,462 20.500% | 0 (Unchanged) | Filing History |
| 2025-02-14 2:00 pm Sale | 2024-12-31 | 13G | Roivant Sciences Ltd. ROIV | QVT Financial LP | 65,793,779 9.220% | -926,000 (-1.39%) | Filing History |
| 2025-02-14 09:59 am Sale | 2024-12-31 | 13G | Roivant Sciences Ltd. ROIV | SB INVESTMENT ADVISERS (UK) LTD | 62,057,537 8.500% | -10,974,130 (-15.03%) | Filing History |
| 2025-01-15 4:30 pm Purchase | 2025-01-13 | 13D | Immunovant, Inc. IMVT | Roivant Sciences Ltd. ROIV | 96,660,341 56.900% | 16,845,010 (+21.10%) | Filing History |
| 2024-11-14 4:31 pm Sale | 2024-09-30 | 13G | Roivant Sciences Ltd. ROIV | VIKING GLOBAL INVESTORS LP | 54,099,066 7.300% | -15,269,895 (-22.01%) | Filing History |
| 2024-11-12 4:58 pm Unchanged | 2024-09-30 | 13G | Roivant Sciences Ltd. ROIV | VANGUARD GROUP INC | 41,683,055 5.630% | 0 (Unchanged) | Filing History |
| 2024-11-12 10:34 am Purchase | 2024-11-08 | 13G | Roivant Sciences Ltd. ROIV | FMR LLC | 49,145,056 6.645% | 49,145,056 (New Position) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Roivant Sciences Ltd. ROIV | BlackRock Inc. BLK | 41,962,059 5.700% | 0 (Unchanged) | Filing |
| 2024-11-04 10:47 am Purchase | 2024-09-30 | 13G | Roivant Sciences Ltd. ROIV | VANGUARD GROUP INC | 41,683,055 5.630% | 41,683,055 (New Position) | Filing History |
| 2024-10-24 2:02 pm Purchase | 2024-09-30 | 13G | Roivant Sciences Ltd. ROIV | BlackRock Inc. BLK | 41,962,059 5.700% | 41,962,059 (New Position) | Filing |
| 2024-04-02 4:06 pm Sale | 2024-04-02 | 13G | Roivant Sciences Ltd. ROIV | Sumitomo Chemical Co. Ltd. | 0 0.000% | -71,251,083 (Position Closed) | Filing History |